In vitro CD40L and BCR stimulation of CLL cells induces increased expression of BCL-XL, Blf-1 and MCL1, with associated resistance to venetoclax, suggesting lymph node microenvironmental signalling may blunt the sensitivity of CLL cells to selective BCL2 inhibition. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.